Biologica Technologies introduces product for bone regeneration

Alan Condon -   Print  |

Orthobiologic company Biologica Technologies on Oct. 6 launched OsseoGen, a cellular bone matrix designed for bone regeneration.

Three things to know:

1. OsseoGen is a dimethyl sulfoxide-free product, which eliminates the need to rinse and decant the tissue before implantation. It is delivered through an open-bore syringe.

2. OsseoGen takes about half the time to thaw, compared to other cellular bone matrixes currently available, according to the company.

3. Biologica's debut product, ProteiOS, was launched for orthopedics and neurosurgery in 2015. The growth factor comprises allogenic bone marrow and can be used with the surgeon's choice of scaffold or matrix.

More articles on biologics:
Dr. Alexander Vaccaro on the 'secret sauce' behind Rothman Orthopaedics' Florida expansion
Renowned UK orthopedic surgeon investigated for collecting bones of 5,000+ patients
Dr. Farzin Kabaei on COVID-19 recovery, herd immunity & threats to private practice

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers